Yüklüyor......
Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
SARS-CoV-2 is a type of beta-CoV that develops acute pneumonia, which is an inflammatory condition. A cytokine storm has been recognized as one of the leading causes of death in patients with COVID-19. ALI and ARDS along with multiple organ failure have also been presented as the consequences of acu...
Kaydedildi:
| Yayımlandı: | Immunopharmacol Immunotoxicol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8146296/ https://ncbi.nlm.nih.gov/pubmed/34015982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08923973.2021.1925293 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|